Methotrexate-associated lymphoproliferative disorder of the heart-Reference-Cited by-同舟云学术

Methotrexate-associated lymphoproliferative disorder of the heart

Published:2024-07-18 Issue: Volume: Page:
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Sumi Toshiyuki¹²^ORCID,Suzuki Keito¹²,Arioka Kotomi³,Chiba Hirofumi²

Affiliation:

1. Hakodate Goryoukaku Hospital Department of Pulmonary Medicine, , Hokkaido, Japan

2. Sapporo Medical University School of Medicine Department of Respiratory Medicine and Allergology, , Sapporo, Japan

3. Hakodate Goryoukaku Hospital Department of Surgical Pathology, , Hokkaido, Japan

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/jjco/advance-article-pdf/doi/10.1093/jjco/hyae091/58587299/hyae091.pdf

Reference6 articles.

1. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective;Harigai;Mod Rheumatol,2018

2. Risk of lymphoma associated with anti-TNF therapy in patients with inflammatory bowel disease: implications for therapy;Dahmus;Clin Exp Gastroenterol,2020

3. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication;Hoshida;J Rheumatol,2007

4. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression;Ichikawa;Eur J Haematol,2013

5. FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis;Kameda;Sci Rep,2022